InstantGMP™, a leading provider of manufacturing and quality management software for regulated industries, proudly announces ...

The market stands on the precipice of unprecedented expansion. Driven by substantial investments, groundbreaking therapeutic pipelines, and advanced technological integration, the industry is poised ...

The company expands its API facility in Waltham, MA, to support the development and manufacturing of peptide therapies.

GMP manufacturing is carried out in a 25,000 foot 2 facility, with 4,000 feet 2 over to clean rooms and the rest devoted to warehousing, QC, and other functions.

Exothera, a Belgium-based CDMO, delivers customized process development and GMP manufacturing services for viral vector–based therapeutics such as gene therapies, cell therapies, oncolytic ...

MIAMI--(BUSINESS WIRE)--OrganaBio, LLC, announces initiation of GMP manufacturing operations at its new cell therapy manufacturing facility, launching a new paradigm in contract and development ...

Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced that Snapdragon ...